,datetime,sentence,positive,negative,neutral,global_sentiment,avg_sentiment
0,2020-03-14 03:25:00,"With fear of COVID-19 running rampant and stocks whipsawing from big losses one day to big gains the next, growth investors (at least, those who manage to resist the urge to hide in a cave) are probably wondering whether any stocks are impervious to the volatility.",0.09482081234455109,0.5565145015716553,0.3486647307872772,negative,-0.4616937041282654
1,2020-03-14 03:25:00,"Perhaps not entirely -- but at least there are companies whose businesses are steady, even if their share prices aren't right now.",0.28654420375823975,0.05692435801029205,0.6565313935279846,neutral,0.2296198457479477
2,2020-03-14 03:25:00,One well-managed company that just keeps growing with few surprises is cloud-based software-as-a-service vendor Veeva Systems (NYSE: VEEV).,0.24353273212909698,0.008034891448915005,0.7484323382377625,neutral,0.23549784719944
3,2020-03-14 03:25:00,"With revenue that comes mostly from subscriptions and a growth strategy that's expanding its user base as well as spending per customer, the company delivers the kind of performance the market values highly.",0.8911929130554199,0.012838955037295818,0.09596817940473557,positive,0.8783539533615112
4,2020-03-14 03:25:00,"Veeva's founder and chief executive officer, Peter Gassner, was an executive vice president at salesforce.com (NYSE: CRM) who recognized the potential of designing cloud-based software for the life sciences industry.",0.30824196338653564,0.00849366094917059,0.683264434337616,neutral,0.2997483015060425
5,2020-03-14 03:25:00,"Where companies in that industry had been using a hodgepodge of software solutions to manage various facets of their businesses, Veeva stepped in to offer an ever-growing suite of software for customer relationship management (CRM) and other functions to support clinical, quality, and regulatory processes.",0.680099606513977,0.01080804318189621,0.30909234285354614,positive,0.6692915558815002
6,2020-03-14 03:25:00,"More of the same last quarter

The fact that Veeva's business is based mainly on subscriptions makes the company almost impervious to negative revenue surprises.",0.18886105716228485,0.528922975063324,0.28221595287323,negative,-0.34006190299987793
7,2020-03-14 03:25:00,"The company has beaten Wall Street's revenue expectations for 20 quarters in a row -- including the most recent quarter, Q4 of fiscal 2020, when the company reported top-line growth of 34% to $311.5 million, compared with the analyst consensus of $298 million.",0.9285631775856018,0.0499725304543972,0.02146429754793644,positive,0.8785906434059143
8,2020-03-14 03:25:00,Subscription revenue was 82% of the total and grew 33% year-over-year.,0.9278523325920105,0.01524991262704134,0.05689774453639984,positive,0.912602424621582
9,2020-03-14 03:25:00,"Non-GAAP earnings per share, which excludes stock-based compensation and amortization of intangible assets related to acquisitions, rose 20% to $0.54, beating the analyst consensus by $0.02.",0.9531024098396301,0.027669766917824745,0.01922779344022274,positive,0.9254326224327087
10,2020-03-14 03:25:00,"For the full fiscal year, Veeva's top line increased 28% on 29% growth in subscription revenue, and adjusted earnings per share were up 34%.",0.9586701393127441,0.020274965092539787,0.021054895594716072,positive,0.9383952021598816
11,2020-03-14 03:25:00,"The company recently raised its guidance for this year, saying it expects 27% top-line growth and a 14% increase in non-GAAP EPS.",0.9439244270324707,0.014015600085258484,0.04206003248691559,positive,0.929908812046051
12,2020-03-14 03:25:00,"Veeva has been so successful selling its products that the growth of its oldest product line, Commercial Cloud for CRM, is slowing just because the company already counts most of the industry's biggest players as customers.",0.025471912696957588,0.8889645338058472,0.08556347340345383,negative,-0.8634926080703735
13,2020-03-14 03:25:00,Commercial Cloud subscription revenue was up just 15% in fiscal 2020.,0.8443781137466431,0.024004468694329262,0.13161736726760864,positive,0.8203736543655396
14,2020-03-14 03:25:00,"But what has enabled Veeva to maintain its spectacular growth rate over so many years is its ability to add new major new product lines, allowing it to expand to new customers or to cross-sell new products to existing ones.",0.9133132696151733,0.011995960026979446,0.07469075173139572,positive,0.901317298412323
15,2020-03-14 03:25:00,"The newer Veeva Vault product line has essentially transformed the company, taking up the slack from slowing sales from CRM.",0.916860818862915,0.017253486439585686,0.06588567048311234,positive,0.8996073603630066
16,2020-03-14 03:25:00,"Subscription revenue growth from Vault was 43% in fiscal 2020, excluding the effect of an acquisition, and now makes up 47% of the company's total subscription revenue, up from 30% three years ago.",0.9515386819839478,0.015955930575728416,0.03250538930296898,positive,0.9355827569961548
17,2020-03-14 03:25:00,"The number of Vault customers was up 25% in the year, with existing customers increasing their spending as they added new applications.",0.9510288238525391,0.01925862766802311,0.0297124944627285,positive,0.9317702054977417
18,2020-03-14 03:25:00,"Commercial Cloud and Vault together are strong enough to generate accelerating revenue growth, but the company is looking ahead to other product lines that could fuel expansion years in the future.",0.8923434019088745,0.012696092016994953,0.09496045112609863,positive,0.8796473145484924
19,2020-03-14 03:25:00,"Veeva has launched Vault products that support quality and regulatory processes for companies in the consumer packaged goods, cosmetics, and chemical industries.",0.23845809698104858,0.006009471602737904,0.755532443523407,neutral,0.23244862258434296
20,2020-03-14 03:25:00,Management estimates that its foray into industries outside life sciences opens up a market opportunity of about $1 billion annually.,0.890458881855011,0.01217349711805582,0.09736759215593338,positive,0.8782854080200195
21,2020-03-14 03:25:00,"But what has CEO Gassner excited now is Veeva's acquisition last year of Crossix, a life-sciences data analytics platform that contains health and non-health data about 300 patients in the U.S. with safeguards to protect patient privacy.",0.23593631386756897,0.01609954796731472,0.7479641437530518,neutral,0.2198367714881897
22,2020-03-14 03:25:00,The company's products enable healthcare businesses such as pharmaceutical companies and hospital systems to conduct targeted marketing campaigns using programmatic advertising.,0.059172872453927994,0.004835600033402443,0.9359915256500244,neutral,0.0543372705578804
23,2020-03-14 03:25:00,"Crossix products allow its clients -- including 160 drug brands, 75 hospitals and health systems, and 50 over-the-counter and consumer brands -- to use programmatic advertising to get their television and digital display ads to target customers.",0.07355928421020508,0.005384792108088732,0.9210559129714966,neutral,0.06817448884248734
24,2020-03-14 03:25:00,It also has analytics to help marketers get insights into targeted patients.,0.1903187334537506,0.006175737362354994,0.803505539894104,neutral,0.18414299190044403
25,2020-03-14 03:25:00,"In the most recent conference call, Gassner called the Crossix acquisition ""transformative,"" drawing a comparison with Vault in its early days.",0.8018038868904114,0.015524307265877724,0.18267180025577545,positive,0.786279559135437
26,2020-03-14 03:25:00,The addition of privacy-safe patient data to Veeva's arsenal opens up new possibilities for enhancing Veeva's existing products.,0.8583599328994751,0.012668762356042862,0.12897129356861115,positive,0.8456911444664001
27,2020-03-14 03:25:00,"Gassner noted that besides contributing 7 percentage points of subscription revenue growth in the most recent quarter, ""the Crossix team has brought new DNA around patients and data into Veeva.""",0.8957563638687134,0.013724553398787975,0.09051905572414398,positive,0.8820317983627319
28,2020-03-14 03:25:00,Last year's acquisition of Crossix and a smaller company that provides speakers bureau services and software for event aren't the last moves the company will make to build on its success.,0.36379116773605347,0.016430186107754707,0.6197786331176758,neutral,0.3473609685897827
29,2020-03-14 03:25:00,"Veeva has over $1 billion in cash with no debt and generated $437 million in operating cash flow last year, so expect it to make other strategic investments when the right opportunities come up.",0.6937339305877686,0.01020453404635191,0.29606151580810547,positive,0.6835293769836426
30,2020-03-14 03:25:00,"Veeva stock is expensive, selling for about 20 times trailing revenue and 16 times this year's expected revenue.",0.0486370287835598,0.05128989741206169,0.9000730514526367,neutral,-0.002652868628501892
31,2020-03-14 03:25:00,"But Wall Street loves the steady, predictable performance of this company and the opportunities it has ahead, and today's valuation is considerably more attractive that the 30 times sales that the shares were selling for last summer.",0.7746319770812988,0.01666785031557083,0.20870018005371094,positive,0.7579641342163086
32,2020-03-14 03:25:00,"Veeva's shares haven't avoided the bloodbath caused by fear of COVID-19, but they've held up better than most stocks, despite their high valuation.",0.9050102829933167,0.059388212859630585,0.03560149297118187,positive,0.8456220626831055
33,2020-03-14 03:25:00,"For 2020, the share price is down 4.5%, compared with a whopping 21% decline for the S&P 500.",0.018550006672739983,0.9698578715324402,0.011592178605496883,negative,-0.9513078927993774
34,2020-03-14 03:25:00,There aren't many places for stock investors to hide from rampant fear over the impact of COVID-19.,0.07017476111650467,0.403179407119751,0.526645839214325,neutral,-0.3330046534538269
35,2020-03-14 03:25:00,"A highly valued stock like Veeva Systems might seem like a counterintuitive buy right now, but a steady-Eddie business that doesn't produce negative surprises can be an antidote to a volatile market.",0.46241486072540283,0.05535800755023956,0.4822271168231964,neutral,0.40705686807632446
36,2020-03-14 03:25:00,"While shares might still fall more from here, long-term investors should consider adding some shares of Veeva at today's price and adding more if the stock falls further.",0.26439782977104187,0.040063805878162384,0.695538341999054,neutral,0.22433403134346008
37,2020-03-14 03:25:00,"10 stocks we like better than Veeva Systems

When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen.",0.12699975073337555,0.025114860385656357,0.8478853702545166,neutral,0.1018848866224289
38,2020-03-14 03:25:00,"After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.",0.46925464272499084,0.07301506400108337,0.4577302634716034,positive,0.39623957872390747
39,2020-03-14 03:25:00,"*

David and Tom just revealed what they believe are the ten best stocks for investors to buy right now... and Veeva Systems wasn't one of them!",0.20886248350143433,0.015013301745057106,0.7761241793632507,neutral,0.19384917616844177
40,2020-03-14 03:25:00,That's right -- they think these 10 stocks are even better buys.,0.8146857619285583,0.02307075634598732,0.16224350035190582,positive,0.7916150093078613
41,2020-03-14 03:25:00,Jim Crumly owns shares of Salesforce.com and Veeva Systems.,0.015823952853679657,0.010220332071185112,0.9739557504653931,neutral,0.005603620782494545
42,2020-03-14 03:25:00,The Motley Fool owns shares of and recommends Salesforce.com and Veeva Systems.,0.03005971759557724,0.018141884356737137,0.9517984390258789,neutral,0.011917833238840103
43,2020-03-14 03:25:00,The Motley Fool has a disclosure policy.,0.016547108069062233,0.01730392687022686,0.9661489725112915,neutral,-0.0007568188011646271
